233 - Clinical Markers of Alzheimer's Disease: September 2021 - a podcast by Anusha Kamesh, Naila Kuhlmann, Ellen Koch, Sarah Louadi, Elyn Rowe

You may have come across a variety of exams used to test cognitive function and assess cognitive decline, such as the Addenbrooke's Cognitive Examination, the mini mental state exam, the clock drawing test, and many more. So how are we doing with these? And how well do they apply in special populations such as people with intellectual disability? Is there room for racial bias in how they are administered? And what translated tests were recently validated? These are topics addressed by papers published in September 2021 in the context of Alzheimer’s disease, presented in the first of this 2-part episode.

Sections in this episode:
Evaluating Existing Cognitive Tests (9:19)
Evaluating Cognitive Tests in Specific Populations (37:19)
Evaluating a Translation of an Existing Cognitive Test (45:14)

Further episodes of AMiNDR: A Month in Neurodegenerative Disease Research

Further podcasts by Anusha Kamesh, Naila Kuhlmann, Ellen Koch, Sarah Louadi, Elyn Rowe

Website of Anusha Kamesh, Naila Kuhlmann, Ellen Koch, Sarah Louadi, Elyn Rowe